Drug Report History #153555
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v7-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-02-23 (Updated) | 2022-01-26 |
| Drug Identification Number | 02125323 | 02125323 |
| Brand name | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG |
| Common or Proper name | hydrochloride Controlled Release Capsules | hydrochloride Controlled Release Capsules |
| Company Name | PURDUE PHARMA | PURDUE PHARMA |
| Ingredients | HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 3MG | 3MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 60 | 60 |
| ATC code | N02AA | N02AA |
| ATC description | OPIOIDS | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-26 | 2022-01-26 |
| Actual start date | 2022-01-26 | 2022-01-26 |
| Estimated end date | 2022-02-28 (Updated) | 2022-02-25 |
| Actual end date | 2022-02-21 (Updated) | |
| Shortage status | Resolved (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |